29835-52-7

Upstream product

• 62934-90-1 2,2-dimethyl-pentane-1,3,5-tricarboxylic acid 
• 274690-12-9 2-cyano-3,3-dimethyl-glutaric acid diethyl ester 
• 872808-07-6 2,2-dimethyl-pentane-1,3,5-tricarboxylic acid triethyl ester 
• 62934-87-6 2-cyano-2-(2-cyano-ethyl)-3,3-dimethyl-glutaric acid diethyl ester 
• 487-51-4 4-carbethoxy-3-methyl-2-cyclohexen-1-one 
• 75-16-1 methylmagnesium bromide 
• 35490-07-4 methyl 2-methyl-4-oxocyclohex-2-enecarboxylate 
• 74-88-4 methyl iodide 
• 1117-96-0 Diazoethan 
• 4029-26-9 2,2-dimethyl-4-oxo-cyclohexanecarboxylic acid 

Downstream Products

• 1522240-51-2 (1S,4S)-4-Hydroxy-2,2-dimethyl-cyclohexanecarboxylic acid methyl ester 
• 29852-03-7 4-Hydroxy-2,2-dimethyl-cyclohexanecarboxylic acid ethyl ester 

Relevant academic research and scientific papers

INHIBITORS OF RET

Inhibitors of wild-type RET and its resistant mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.

PYRAZOLE AMIDE DERIVATIVE

The present invention relates to a novel compound having a function of inhibiting RORγ activity. The present invention also relates to pharmaceutical composition comprising the compound, a use of the compound in treating or preventing autoimmune diseases, inflammatory diseases, metabolic diseases, or cancer diseases.